Global Preventable Vaccines Market, By Technology (Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Others), Indication (Pneumococcal Disease, Influenza, Polio, Hepatitis, Others), Route of Administration (Oral, Parenteral), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.
Preventable Vaccines Market Analysis and Size
The global preventable vaccines market is expected to witness significant growth during the forecast period. The global preventable vaccines market is driven by the growing occurrence of chronic conditions such as flu and bacterial infections and the launch of numerous newer vaccines annually. Rising incidence of diseases among children results in implementation of several awareness programs by governments worldwide. Furthermore, significant advancements in vaccinology, such as the emergence, development, and usage of hepatitis B vaccine, should expand the business growth in the coming years. COVID-19 also had a major impact on the market growth.
Data Bridge Market Research analyses a growth rate in the global preventable vaccines market in the forecast period 2022-2029. The expected CAGR of global preventable vaccines market is tend to be around 5.90% in the mentioned forecast period. The market was valued at USD 60.49 billion in 2021, and it would grow upto USD 95.69 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Preventable vaccines are the type of biological therapeutics that aims to prevent the infectious diseases. The preventive vaccines either boost the immunity or stimulate the production of antibodies that will fight against potential infectious diseases.
Preventable Vaccines Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Technology (Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Others), Indication (Pneumococcal Disease, Influenza, Polio, Hepatitis, Others), Route of Administration (Oral, Parenteral), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Pfizer Inc. (U.S.), GSK plc (U.K.), Novartis AG (Switzerland), Mylan N.V. (U.S.), Sanofi (France), Boehringer Ingelheim International GmbH. (Germany), Merck & Co., Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Bristol-Myers Squibb Company (U.S.), Bharat Biotech (India), Serum Institute of India Pvt. Ltd (India), EMERGENT (U.S.)
|
|
Market Opportunities
|
|
Global Preventable Vaccines Market Dynamics
Drivers
- Rising Awareness
In the last few years, government and non-government organizations in developing countries, have taken extreme efforts to raise awareness for preventive medicine. Several programs have been conducted that reach out to uneducated people, especially in rural areas. This is a key factor that boosts the preventable vaccines market in the world's emerging economies.
- Rising Demand for Oral Drugs
Oral drugs is expected to boost the market growth. The segment is expected to accelerate the global market as most products are available in capsule and tablet form and it is a very feasible route of administration.
Opportunities
- Increasing Demand for Retail Pharmacies
The rise in the number of preventable vaccines delivered through retail pharmacies and the surge in the number of retail pharmacies in developed countries create opportunities for the market growth. In addition to this, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.
- Technological Advancements
Several technologies has been developed for immunization that has made enormous strides over the past ten years, which have changed how vaccines are developed. The introduction of genetic engineering technique has flashed numerous improvements in vaccine development programs and led to the launch of new products. Several virus vaccines that take advantage of the attenuated state of the virus have been developed through these methods. This creates opportunity for the market growth.
Restraints/Challenges
- Lack of skilled professionals
The lack of trained healthcare professionals who are unable to treat these patients with suitable treatments could restrict the growth of the global preventable vaccines market during the forecast period.
- Side Effects of Bacterial Vaccines
Many side effects associated with preventable vaccines surely hamper the market growth. Side effects such as fever, chills, enduration, pain and soreness, and many such effects restrain the growth of the market.
This global preventable vaccines market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global preventable vaccines market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Preventable Vaccines Market Scope
The global preventable vaccines market is segmented on the basis of technology, indication, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Technology
- Inactivated Vaccines
- Live Attenuated Vaccines
- Toxoid Vaccines
- Others
Indication
- Pneumococcal Disease
- Influenza
- Polio
- Hepatitis
- Others
Route of Administration
- Oral
- Parenteral
End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Preventable Vaccines Market Regional Analysis/Insights
The global preventable vaccines market is analysed and market size insights and trends are provided by technology, indication, route of administration, distribution channel and end-user as referenced above.
The major countries covered in the global preventable vaccines market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America has been witnessing a positive growth for global preventable vaccines market throughout the forecasted period due to the presence of refined healthcare expenditure, increased patient awareness level, and high incidence of infectious diseases.
Asia-Pacific dominates the market due to the presence of global marketed players in this region and growing government support for vaccine development.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Preventable Vaccines Market Share Analysis
The global preventable vaccines market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global preventable vaccines market.
Key players operating in the global preventable vaccines market include:
- Pfizer Inc. (U.S.)
- GSK plc (U.K.)
- Novartis AG (Switzerland)
- Mylan N.V. (U.S.)
- Sanofi (France)
- Boehringer Ingelheim International GmbH. (Germany)
- Merck & Co., Inc. (U.S.)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Bristol-Myers Squibb Company (U.S.)
- Bharat Biotech (India)
- Serum Institute of India Pvt. Ltd (India)
- EMERGENT (U.S.)
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.
The key
SKU-